Correction Volume 10, Issue 11 pp 3626
Correction: MicroRNA-939 inhibits cell proliferation via targeting LRSAM1 in Hirschsprung’s disease
- 1 State Key Laboratory of Reproductive Medicine, Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, China
- 2 Key Laboratory of Modern Toxicology (Nanjing Medical University), Nanjing, China
- 3 Department of Pediatric Surgery, Children’s Hospital of Nanjing Medical University, Nanjing 210008, China
- 4 Department of Endocrinology and Metabolism, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
Published: November 12, 2018
https://doi.org/10.18632/aging.101650How to Cite
Original article: Aging (Albany NY) 2017; 9:2471-2479.
This article has been corrected: The authors have submitted the wrong composite of Figure 1 (C), the mistake was in the 293T and SH-SY5Y cell line. The corrected panel C of Figure 1 is provided below. The authors declare that this correction does not change the results or conclusions of this paper. The authors sincerely apologize for this error.
Figure 1. Mir-939 was upregulated in HSCR tissues and cytobiology change after treating cells with its mimics. (A) Mir-939 was significantly overexpressed in HSCR (n=80) tissues compared with control samples (n=80). Human 293T, SK-N-BE(2), SH-SY5Y cell lines were transfected with miR-939 mimics, upregulated mir-939 suppressed cell proliferation indicated by the CCK-8 assay (B) without impact on cell migration (C), cell cycle (D) and cell apoptosis (E). *indicates significant difference compared with control group, P<0.05.